504 related articles for article (PubMed ID: 32449374)
1. Laboratory findings of COVID-19: a systematic review and meta-analysis.
Zhang ZL; Hou YL; Li DT; Li FZ
Scand J Clin Lab Invest; 2020 Oct; 80(6):441-447. PubMed ID: 32449374
[TBL] [Abstract][Full Text] [Related]
2. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
[TBL] [Abstract][Full Text] [Related]
3. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
Sun DW; Zhang D; Tian RH; Li Y; Wang YS; Cao J; Tang Y; Zhang N; Zan T; Gao L; Huang YZ; Cui CL; Wang DX; Zheng Y; Lv GY
Clin Chim Acta; 2020 Sep; 508():122-129. PubMed ID: 32417210
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.
Huang G; Kovalic AJ; Graber CJ
Emerg Infect Dis; 2020 Aug; 26(8):1839-1841. PubMed ID: 32384045
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
[TBL] [Abstract][Full Text] [Related]
8. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.
Henry BM; Benoit SW; de Oliveira MHS; Hsieh WC; Benoit J; Ballout RA; Plebani M; Lippi G
Clin Biochem; 2020 Jul; 81():1-8. PubMed ID: 32473151
[TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.
Poggiali E; Zaino D; Immovilli P; Rovero L; Losi G; Dacrema A; Nuccetelli M; Vadacca GB; Guidetti D; Vercelli A; Magnacavallo A; Bernardini S; Terracciano C
Clin Chim Acta; 2020 Oct; 509():135-138. PubMed ID: 32531257
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
11. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.
Yamada T; Wakabayashi M; Yamaji T; Chopra N; Mikami T; Miyashita H; Miyashita S
Clin Chim Acta; 2020 Oct; 509():235-243. PubMed ID: 32533986
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
Li T; Wang L; Wang H; Gao Y; Hu X; Li X; Zhang S; Xu Y; Wei W
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2447-2455. PubMed ID: 32613308
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and the clinical hematology laboratory.
Frater JL; Zini G; d'Onofrio G; Rogers HJ
Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):11-18. PubMed ID: 32311826
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
Li LQ; Huang T; Wang YQ; Wang ZP; Liang Y; Huang TB; Zhang HY; Sun W; Wang Y
J Med Virol; 2020 Jun; 92(6):577-583. PubMed ID: 32162702
[TBL] [Abstract][Full Text] [Related]
15. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
16. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Moutchia J; Pokharel P; Kerri A; McGaw K; Uchai S; Nji M; Goodman M
PLoS One; 2020; 15(10):e0239802. PubMed ID: 33002041
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.
Li M; Dong Y; Wang H; Guo W; Zhou H; Zhang Z; Tian C; Du K; Zhu R; Wang L; Zhao L; Fan H; Luo S; Hu D
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1061-1067. PubMed ID: 32456948
[TBL] [Abstract][Full Text] [Related]
18. Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data.
Gatti M; Calandri M; Barba M; Biondo A; Geninatti C; Gentile S; Greco M; Morrone V; Piatti C; Santonocito A; Varello S; Bergamasco L; Cavallo R; Di Stefano R; Riccardini F; Boccuzzi A; Limerutti G; Veltri A; Fonio P; Faletti R
Radiol Med; 2020 Dec; 125(12):1271-1279. PubMed ID: 32894449
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
[No Abstract] [Full Text] [Related]
20. Clinical Characteristics of 3 Patients Infected with COVID-19: Age, Interleukin 6 (IL-6), Lymphopenia, and Variations in Chest Computed Tomography (CT).
Huang J; Li J; Zou Z; Kandathil A; Liu J; Qiu S; Oz OK
Am J Case Rep; 2020 Oct; 21():e924905. PubMed ID: 33052896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
